BUPA OCCUPATIONAL HEALTH LIMITED
Get an alert when BUPA OCCUPATIONAL HEALTH LIMITED files next
Leroy will email you the moment a new filing lands at Companies House — one short note per filing, nothing else.
Next accounts due
2026-09-30 (in 4mo)
Last filed for 2024-12-31
Confirmation statement due
2026-07-04 (in 2mo)
Last made up 2025-06-20
Watchouts
None on the register
Cash
£125K
-90.7% vs 2023
Net assets
£9M
-5.1% vs 2023
Employees
1,530
+62.1% vs 2023
Profit before tax
-£72K
-194.7% vs 2023
Net assets
2-year trend · vs Health Care median
Accounts
2-year trend · latest reflected 2024-12-31
| Metric | Trend | 2023-12-31 | 2024-12-31 |
|---|---|---|---|
| Turnover | £109,182,000 | £157,886,000 | |
| Operating profit | — | — | |
| Profit before tax | £76,000 | -£72,000 | |
| Net profit | -£63,000 | -£486,000 | |
| Cash | £1,345,000 | £125,000 | |
| Total assets less current liabilities | £23,488,000 | £26,710,000 | |
| Net assets | £9,534,000 | £9,048,000 | |
| Equity | £9,534,000 | £9,048,000 | |
| Average employees | 944 | 1,530 | |
| Wages | £32,996,000 | £58,369,000 |
Values shown as filed in the company's annual accounts. — indicates the figure wasn't present under that line item in that period. About these numbers
Ratios
Computed from the line items above — sparklines read oldest → newest
| Ratio | Trend | 2023-12-31 | 2024-12-31 |
|---|---|---|---|
| Net margin | -0.1% | -0.3% | |
| Current ratio | 0.68x | 0.52x |
Margins divide P&L lines by turnover. Gearing is liabilities over total assets. Current ratio is current assets over creditors falling due within one year. Interest cover is operating profit over absolute finance costs. Sector-distribution context coming next.
Audit & accounting basis
- Accounting basis
- FRS 101
- Reporting scope
- Standalone (parent only)
- Auditor
- PricewaterhouseCoopers LLP
- Audit opinion
- Unqualified (clean)
- Going concern
- Affirmed
“The financial statements have been prepared on a going concern basis which the directors consider to be appropriate for the following reasons. The Company meets its day-to-day working capital requirements through its cash reserves and borrowings. As of 31 December 2024, the Company had no external debt and had access to a funding facility provided by Bupa Finance plc, an intermediate parent company. The Directors have prepared cash flow forecasts collectively for the entities which make up Bupa Clinics ('BC') for a period of at least 12 months from the date of approval of these financial statements which indicate that BC will require the financial support of the Bupa Group. Those forecasts are not specific to individual entities within the BC companies, as such, no absolute certainty can be gained from them for each individual entity. Therefore, the Company is dependent on Bupa Finance plc providing additional financial support during that period. Bupa Finance plc has indicated its intention to continue to make available such funds as are needed by the Company, and that it does not intend to seek repayment of the amounts due at the balance sheet date to itself and other-members of the Bupa Finance plc group of £54,291,000, unless adequate alternative financing has been secured by the Companies, for at least 12 months from the date of approval of these financial statements. As with any company placing reliance on other group entities for financial support, the Directors acknowledge that there can be no certainty that this support will continue although, at the date of approval of these financial statements, they have no reason to believe it will not do so. Bupa Finance plc's going concern status has been considered and based on its current position, forecast results, including reasonably possible changes in trading performance, and solvency capital, it has been concluded that Bupa Finance plc has adequate resources to operate for at least the next 12 months from the approval of these financial statements. Therefore the Directors are confident that Bupa Finance plc can provide financial support up to the level required for at least the next 12 months from the date of approving the financial statements. Consequently, the Directors are confident that the Company will have sufficient funds to continue to meet its liabilities as they fall due for at least 12 months from the date of approval of the financial statements and therefore have prepared the financial statements on a going concern basis.”
Group structure
- BUPA OCCUPATIONAL HEALTH LIMITED · parent
- Occupational Health Care Limited 100%
- Bupa Diagnostic & Secondary Care (London) Limited 100%
- Metabolic Services Limited 100%
- Blackberry Clinics Group Limited 100%
- Blackberry Clinic Limited 100%
- Blackberry Clinic (Ipswich) Limited 100%
- Blackberry Gymnasium Limited 100%
- Blackberry Clinic Aberdeen Limited 100%
- Blackberry Clinic Croydon Limited 100%
- Blackberry Clinic (Havant) Ltd 100%
- TDP Bidco Limited 100%
- Canterbury Skin and Laser Clinic Limited 100%
- Everything Skin Limited 100%
- The Harley Street Dermatology Clinic Ltd 100%
- St Michael's Clinic Ltd 100%
- Stratum Aesthetics Limited 100%
- Stratum Clinics Limited 100%
Significant events
- “On 8 August 2025, the Company completed the acquisition of the shares of The New Victoria Hospital Limited, for a consideration of £1 and £45,900,000 of external debt paid”
- “On 7 August 2025, the Company issued 57,654,077 ordinary shares of £1 each for cash consideration of £57,654,077 and purchased a further 10,700,000,000 shares of £0 001 for cash consideration of £10,700,000 in its subsidiary company Bupa Diagnostic & Secondary Care (London) Limited (formerly known as Metholdco Limited)”
Auditor, going-concern and subsidiary information is drawn from the narrative of the latest annual accounts. About these numbers
People
6 active · 49 resigned
| Name | Role | Appointed | Born | Nationality |
|---|---|---|---|---|
| BUPA SECRETARIES LIMITED | Corporate Secretary | 2005-09-01 | — | — |
| EDMUNDSON, Robert John | Director | 2021-03-31 | Nov 1978 | British |
| LEDSHAM, Stephen | Director | 2023-08-02 | Jun 1983 | British |
| MELIA, Sarah | Director | 2018-05-17 | Dec 1971 | British |
| PAICE, Joanna Ruth | Director | 2021-03-31 | Jul 1977 | British |
| SIMIC, Petra, Dr | Director | 2022-06-14 | Jul 1976 | British |
Show 49 resigned officers
| Name | Role | Appointed | Resigned |
|---|---|---|---|
| ABRAHAM, Richard John | Secretary | — | 1994-09-23 |
| KEE, Fergus Alexander | Secretary | 1994-09-23 | 1999-02-04 |
| WALFORD, Arthur David | Secretary | 1999-02-04 | 2005-09-01 |
| ABRAHAM, Richard John | Director | — | 1994-09-23 |
| BAILEY, Alan Richard, Doctor | Director | — | 1993-09-30 |
| BARKER, James | Director | — | 1993-05-17 |
| BARKER, Neil Stephen | Director | 2011-04-04 | 2012-12-10 |
| BEAZLEY, Nicholas Tetley | Director | 2005-09-01 | 2013-05-19 |
| BIDDLESTONE, Keith | Director | — | 1994-10-17 |
| BROWN, Catherine | Director | 2001-11-18 | 2006-12-04 |
| BURNS, Robert Ian | Director | 1995-11-17 | 1999-02-04 |
| BURNS, Robert Ian | Director | 1993-10-06 | 1995-10-18 |
| CLOSE, Wayne Paul | Director | 2018-05-17 | 2021-03-31 |
| DAVIES, Julian Peter | Director | 1996-11-21 | 2008-05-23 |
| DE FREITAS, Joao Paulo Mcalpine | Director | 2009-11-02 | 2012-08-31 |
| DONALD, Alan Charles | Director | 1998-03-27 | 1999-02-04 |
| DUGDALE, Michael Ian | Director | 2002-01-01 | 2009-11-02 |
| ELLEN, Susan Caroline | Director | — | 1995-09-29 |
| ELLERBY, Mark | Director | 1996-09-12 | 1998-03-27 |
| ELLIOTT, Joan Martina | Director | 2013-04-22 | 2015-10-29 |
| ELLIOTT, Paul John | Director | 2011-04-04 | 2013-04-29 |
| FIELDHOUSE, Philippa Jane | Director | 2016-09-27 | 2018-05-17 |
| FLANAGAN, Stephen David | Director | 2006-12-04 | 2008-11-10 |
| FLETCHER, Tracey | Director | 2013-04-19 | 2014-04-30 |
| GRAY, Duncan Archibald | Director | 2001-10-15 | 2005-03-15 |
| GREGORY, Fraser David | Director | 2007-11-01 | 2010-06-21 |
| HALL, Michael Andrew | Director | 1993-10-06 | 1995-11-17 |
| HARRISON, Michael | Director | 2018-05-17 | 2023-07-31 |
| HOLDEN, Dean Allan | Director | 1999-02-04 | 2001-12-31 |
| HOLLINGSWORTH, Clare Margaret | Director | 2001-10-15 | 2005-09-01 |
| HYNAM, David Emmanuel | Director | 2014-07-01 | 2015-07-23 |
| KEE, Fergus Alexander | Director | 2005-09-01 | 2008-11-03 |
| KEE, Fergus Alexander | Director | 1994-09-23 | 2001-10-31 |
| KENT, Benjamin David Jemphrey | Director | 2005-09-01 | 2007-11-01 |
| KING, Raymond | Director | 2001-08-01 | 2008-05-15 |
| LEA, Edward William | Director | 1996-11-21 | 2001-09-13 |
| LINTON, Joy | Director | 2015-10-29 | 2016-09-14 |
| LOS, Steven Michael | Director | 2010-06-21 | 2014-07-01 |
| LUCE, Philip Anthony Enright | Director | 2015-10-29 | 2021-03-31 |
| MACDONALD, Natalie-Jane Anne, Dr | Director | 2008-11-03 | 2013-01-31 |
| MERCHANT, Mahboob Ali | Director | 2008-05-23 | 2012-12-10 |
| OWEN, Elizabeth | Director | 1995-10-18 | 1996-11-21 |
| PEELER, Andrew Michael | Director | 2012-12-01 | 2015-02-28 |
| PICKEN, Jonathan Stephen | Director | 2014-07-01 | 2018-05-17 |
| RICHARDSON, Charles Austen | Director | 2018-05-17 | 2020-08-14 |
| THIYAGARAJAN, Arun, Dr | Director | 2021-03-31 | 2023-08-02 |
| WALFORD, Arthur David | Director | 1996-11-21 | 2005-09-01 |
| WATSON, Robert Ian | Director | 1994-10-17 | 1996-11-21 |
| WRIGHT, Jake Hockley | Director | 2018-07-03 | 2022-06-14 |
Ownership
Persons with significant control
| Name | Kind | Nature of control | Notified | Status |
|---|---|---|---|---|
| Bupa Investments Limited | Corporate entity | Shares 75–100%, Voting 75–100%, Appoints directors | 2016-04-06 | Active |
Filing timeline
Last 20 of 281 total filings
| Date | Type | Category | Description | |
|---|---|---|---|---|
| 2025-12-02 | SH01 | capital | Capital allotment shares | |
| 2025-10-16 | AA | accounts | Accounts with accounts type full | |
| 2025-08-07 | SH01 | capital | Capital allotment shares | |
| 2025-06-25 | CS01 | confirmation-statement | Confirmation statement with no updates | |
| 2024-10-10 | AA | accounts | Accounts with accounts type full | |
| 2024-06-25 | CS01 | confirmation-statement | Confirmation statement with no updates | |
| 2023-12-12 | AA | accounts | Accounts with accounts type full | |
| 2023-08-17 | TM01 | officers | Termination director company with name termination date | |
| 2023-08-17 | AP01 | officers | Appoint person director company with name date | |
| 2023-08-09 | TM01 | officers | Termination director company with name termination date | |
| 2023-06-27 | CS01 | confirmation-statement | Confirmation statement with no updates | |
| 2022-10-04 | AA | accounts | Accounts with accounts type full | |
| 2022-06-27 | CS01 | confirmation-statement | Confirmation statement with updates | |
| 2022-06-23 | AP01 | officers | Appoint person director company with name date | |
| 2022-06-23 | TM01 | officers | Termination director company with name termination date | |
| 2021-12-30 | RESOLUTIONS | resolution | Resolution | |
| 2021-12-16 | SH01 | capital | Capital allotment shares | |
| 2021-07-20 | AA | accounts | Accounts with accounts type full | |
| 2021-06-25 | CS01 | confirmation-statement | Confirmation statement with no updates | |
| 2021-04-06 | AP01 | officers | Appoint person director company with name date |
Public-record activity
Raw counts from Companies House — last 12–24 months
- Filings
- 4
- Capital events
- 2
- Officers appointed
- 0
- Officers resigned
- 0
last 12 months
last 24 months
last 12 months
last 12 months
Direct counts from the register. No score, no rating — see the Filing timeline for the underlying events.
Year-on-year
FY2023 → FY2024 · period ending 2024-12-31 vs 2023-12-31
-
Turnover
+44.6%
£109,182,000 £157,886,000
-
Cash
-90.7%
£1,345,000 £125,000
-
Net assets
-5.1%
£9,534,000 £9,048,000
-
Employees
+62.1%
944 1,530
-
Profit before tax
-194.7%
£76,000 -£72,000
-
Wages
+76.9%
£32,996,000 £58,369,000
Each % is (latest − prior) ÷ |prior| for the line item as filed. Periods don't have to be exactly 12 months apart — a long or short period (typical around incorporation or year-end changes) will distort the comparison. Lines a company doesn't report are omitted. About these numbers